Results 181 to 190 of about 44,397 (250)

Anticonvulsant Therapy in Trigeminal Neuralgia: A Class-Oriented Systematic Review. [PDF]

Medicines (Basel)
Pinto Moreira M, Carneiro BD, Faria CS, Pozza DH, Fonseca S.   +4 more
europepmc   +1 more source

Contrast‐Induced Encephalopathy Following Elective Endovascular Aneurysm Treatment: The Role of Dual‐Energy CT and Correlation With Delphi Diagnostic Criteria

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Contrast‐induced encephalopathy (CIE) is an increasingly recognised neurological complication of iodinated contrast administration during neurointerventional procedures. Recently published 2025 Delphi‐based diagnostic criteria and management algorithms aim to standardise clinical practice; however, optimal neuroimaging strategies ...
Kaiwen Cabbabe, Charles Li, Shuangyue Tan, Lisa Broadley, Gerard S. Goh, Cameron Williams, Conor Houlihan, Helen Kavnoudias, Steve Bush, Carlos Chung, Winston Chong   +10 more
wiley   +1 more source

Dental drugs with proarrhythmic risk in patients with Brugada syndrome: precaution instructions for practices in the field of orofacial pain. [PDF]

Front Cardiovasc Med
Han D, Cho NY, Cho ES, Roh SY.
europepmc   +1 more source

Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality.
Fernando Daibert de Souza Motta, Matheus de Lima Ruffini, Amanda Cunha Ritter, Sofia Moreira Ferrão, Rodrigo Sousa Silva, Nicole da Silva Mastella, Bruno Braga Montezano, Elias Ajub Neto, Flávio Kapczinski, Jairo Vinícius Pinto, Ives Cavalcante Passos   +10 more
wiley   +1 more source

Optimizing Treatment Strategies in the Bipolar Disorder Spectrum With Classical AI Approaches: Systematic Review of Performance, Bias, and Clinical Applicability. [PDF]

JMIR Ment Health
De Francesco S, Archetti D, Baronio CM, Demaria C, Boccali A, Crema C, Tura GB, Redolfi A.   +7 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Targeted Comprehensive Screening of Neuropsychiatric Drugs in Serum by LC-MS/MS: Method Development and Three-Year Clinical Utility. [PDF]

Drug Des Devel Ther
Chong E, Koo SE, Kim SM, Chun M, Joo EY, Jeon HJ, Lee SY.   +6 more
europepmc   +1 more source

Clobazam to preserve meaningful engagement in prolonged disorder of consciousness with concurrent seizure disorder

PM&R, EarlyView.
Tatiana Bernstein, Zachary Miklja, Tiffany Wood, Joshua Startup   +3 more
wiley   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source